Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Side effects of alpha interferon in chronic hepatitis C.

Dusheiko G.

Hepatology. 1997 Sep;26(3 Suppl 1):112S-121S. Review.

PMID:
9305675
2.

[Side effects during interferon-alpha therapy of hepatitis C with special consideration of thyroid dysfunction].

Obołończyk L, Obołończyk L, Siekierska-Hellmann M, Sworczak K.

Postepy Hig Med Dosw (Online). 2007 Jun 26;62:309-21. Review. Polish.

3.

Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment.

Piccinino F, Felaco FM, Sagnelli E, Aprea L, Messina V, Pasquale G, Filippini P, Scolastico C.

Res Virol. 1998 Sep-Oct;149(5):283-91.

PMID:
9879606
4.

Side effects of high-dose interferon therapy for chronic hepatitis C.

Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, Nishioji K, Katagishi T, Nakagawa Y, Tada H, Sawa Y, Mizuno M, Kagawa K, Kashima K.

J Hepatol. 1996 Sep;25(3):283-91.

PMID:
8895006
5.

A prospective evaluation of dermatological side-effects during alpha-interferon therapy for chronic viral hepatitis.

Dalekos GN, Christodoulou D, Kistis KG, Zervou EK, Hatzis J, Tsianos EV.

Eur J Gastroenterol Hepatol. 1998 Nov;10(11):933-9.

PMID:
9872615
6.

Multicenter randomized study comparing initial daily induction with high dose lymphoblastoid interferon vs. standard interferon treatment for chronic hepatitis C.

Diago M, Suárez D, García-Villarreal L, Castro A, Domínguez A, Pardo M, del Olmo JA, Pérez-Hernández F, Aguilar J, Quiroga JA, Carreño V.

J Med Virol. 2001 Aug;64(4):460-5.

PMID:
11468730
7.

Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C.

Pittau E, Bogliolo A, Tinti A, Mela Q, Ibba G, Salis G, Perpignano G.

Clin Exp Rheumatol. 1997 Jul-Aug;15(4):415-9. Review.

PMID:
9272304
8.

Immune thrombocytopenia and alpha-interferon therapy.

Dourakis SP, Deutsch M, Hadziyannis SJ.

J Hepatol. 1996 Dec;25(6):972-5.

PMID:
9007728
9.

Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.

Rocha CM, Perez RM, Narciso JL, Ferreira AP, Lemos LB, Medina-Pestana JO, Silva AE, Ferraz ML.

Eur J Gastroenterol Hepatol. 2007 Feb;19(2):119-23.

PMID:
17272996
11.

Consensus interferon: a novel interferon for the treatment of hepatitis C.

Heathcote J.

J Viral Hepat. 1998 Sep;5 Suppl 1:13-8.

PMID:
9795924
12.

Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C.

Gaeta GB, Precone DF, Felaco FM, Bruno R, Spadaro A, Stornaiuolo G, Stanzione M, Ascione T, De Sena R, Campanone A, Filice G, Piccinino F.

Aliment Pharmacol Ther. 2002 Sep;16(9):1633-9.

13.

Therapy of hepatitis C: re-treatment with alpha interferon.

Alberti A, Chemello L, Noventa F, Cavalletto L, De Salvo G.

Hepatology. 1997 Sep;26(3 Suppl 1):137S-142S. Review.

PMID:
9305679
14.

Leucocyte interferon-alpha for patients with chronic hepatitis C intolerant to other alpha-interferons.

Tripi S, Soresi M, Di Gaetano G, Carroccio A, Giannitrapani L, Vuturo O, Di Giovanni G, Montalto G.

BioDrugs. 2003;17(3):201-5.

PMID:
12749756
15.

The use of interferon-alpha in virus infections.

Finter NB, Chapman S, Dowd P, Johnston JM, Manna V, Sarantis N, Sheron N, Scott G, Phua S, Tatum PB.

Drugs. 1991 Nov;42(5):749-65. Review.

PMID:
1723372
16.

[Hypothyroidism as a complication of the treatment of hepatitis C with interferon].

Gomollón García F, Simón Marco MA, Vela J, García López S, Fuentes Olmo J.

An Med Interna. 1996 Sep;13(9):438-40. Spanish.

PMID:
9132035
17.

[Natural history of dysthyroidism during interferon treatment of chronic hepatitis C].

Mekkakia-Benhabib C, Marcellin P, Colas-Linhart N, Castel-Nau C, Buyck D, Erlinger S, Bok B.

Ann Endocrinol (Paris). 1996;57(5):419-27. French.

PMID:
8991106
18.

Spotlight on peginterferon-alpha-2a (40KD) in chronic hepatitis C.

Perry CM, Jarvis B.

BioDrugs. 2002;16(3):213-7. Review.

PMID:
12102649
19.

[The neuropsychiatric side effects of the interferon therapy in patients with chronic hepatitis B and C].

Lapiński TW, Prokopowicz D.

Pol Merkur Lekarski. 1999 Jul;7(37):8-11. Polish.

PMID:
10522402
20.

Interferon alpha with ribavirin for the treatment of chronic hepatitis C in non-responders or relapsers to interferon monotherapy.

Moreno-Monteagudo JA, Fernández-Bermejo M, García-Buey L, Sanz P, Iacono LO, García-Monzón C, Borque MJ, Moreno-Otero R.

Aliment Pharmacol Ther. 1998 Aug;12(8):717-23.

Items per page

Supplemental Content

Write to the Help Desk